| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/01/2010 | US20100168216 Prostaglandin pharmaceutical compositions |
| 07/01/2010 | US20100168215 Methods and compositions for the treatment of neurological disease |
| 07/01/2010 | US20100168214 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer |
| 07/01/2010 | US20100168213 Protein-coding RNA to correct mitochondrial dysfunction |
| 07/01/2010 | US20100168212 Oligomers |
| 07/01/2010 | US20100168211 Hereditary cataract status in canines based on hsf4 gene marker |
| 07/01/2010 | US20100168210 T-Cell Cytokine-Inducing Surface Molecules and Methods of Use |
| 07/01/2010 | US20100168209 Apoptosis inducer for cancer cell |
| 07/01/2010 | US20100168208 RNA INTERFERENCE MEDIATED TREATMENT OF ALZHEIMER'S DISEASE USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 07/01/2010 | US20100168207 Compositions and methods for sirna inhibition of angiogenesis |
| 07/01/2010 | US20100168206 GNAQ Targeted dsRNA Compositions And Methods For Inhibiting Expression |
| 07/01/2010 | US20100168205 Methods and Compositions for Prevention or Treatment of RSV Infection Using Modified Duplex RNA Molecules |
| 07/01/2010 | US20100168204 Therapeutic uses of inhibitors of RTP801L |
| 07/01/2010 | US20100168203 Adenylyl cyclases as novel targets for antibactrial interventions |
| 07/01/2010 | US20100168202 Rad 9 as a diagnostic,prognostic,and therapeutic tool for prostate cancer |
| 07/01/2010 | US20100168201 Polymorphs of [R-(R*, R*) ]-2-(4-Fluorophenyl)-Beta, Delta-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)Carbonyl]-1H-Pyrrole-1-Heptanoic Acid Magnesium Salt (2:1) |
| 07/01/2010 | US20100168199 Kinase Inhibitors |
| 07/01/2010 | US20100168198 Mitochondria-targeted antioxidant prodrugs and methods of use |
| 07/01/2010 | US20100168197 Muscarinic receptor antagonists |
| 07/01/2010 | US20100168196 N-Substituted (Benzoimidazol-2-yl)phenylamines, Processes for Their Preparation, Their Use as a Medicament or Diagnostic Aid, and a Medicament Comprising Them |
| 07/01/2010 | US20100168195 Derivatives and analogs of chroman as functionally selective alpha2c adrenoreceptor agonists |
| 07/01/2010 | US20100168194 Amino-5-[4-(difluoromethoxy)phenyl]-5-phenylimidazolone Compounds For The Inhibition Of Beta-secretase |
| 07/01/2010 | US20100168193 Therapeutic use of imidazole-5-carboxylic acid derivatives |
| 07/01/2010 | US20100168192 Benzisoxazole derivatives as potassium channel modulators for the treatment of e.g. respiratory diseases, epilepsy and convulsions |
| 07/01/2010 | US20100168191 Pharmaceutical formulation comprising pramipexole |
| 07/01/2010 | US20100168190 Novel azoles and related derivatives as non-nucleoside reverse transcriptase inhibitors (nnrtis) in antiviral therapy (hiv) |
| 07/01/2010 | US20100168189 Therapeutic substituted lactams |
| 07/01/2010 | US20100168188 Estrogen Receptor Modulators |
| 07/01/2010 | US20100168187 Therapeutic combination |
| 07/01/2010 | US20100168186 Pre-Mixed, Ready-To-Use Pharmaceutical Compositions |
| 07/01/2010 | US20100168184 Small molecule bcl-x1/bcl-2 binding inhibitors |
| 07/01/2010 | US20100168183 Subsituted cyclic compound, its preparation process and its medical use |
| 07/01/2010 | US20100168182 Compounds and compositions as kinase inhibitors |
| 07/01/2010 | US20100168181 Benzimidazole amido derivatives, their manufacture and use as pharmaceutical agents |
| 07/01/2010 | US20100168180 Novel Compounds |
| 07/01/2010 | US20100168179 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations |
| 07/01/2010 | US20100168176 Novel compounds, pharmaceutical compositions containing same, and methods of use for same |
| 07/01/2010 | US20100168174 Combination of AMPA Receptor Antagonists and Acetylcholinesterase Inhibitors for the Treatment of Neuropathic Pain |
| 07/01/2010 | US20100168173 Heterocycles substituted pyridine derivatives and antifungal agent containing thereof |
| 07/01/2010 | US20100168171 Piperidinone Carboxamide Derivatives as P2X7 Modulators |
| 07/01/2010 | US20100168170 Piperidinones Useful in the Treatment of Inflammation |
| 07/01/2010 | US20100168169 Substituted 1,3-dioxanes useful as ppar modulators |
| 07/01/2010 | US20100168168 Aminoaryl sulphonamide derivatives as functional 5-HT6 ligands |
| 07/01/2010 | US20100168167 Piperidinones Useful in the Treatment of Inflammation |
| 07/01/2010 | US20100168166 Method of Providing An Antihistaminic Effect in a Hepatically Impaired Patient |
| 07/01/2010 | US20100168165 Method of treating disease involving myelin and/or axonal loss |
| 07/01/2010 | US20100168164 Antidiabetic Oxazolidinediones and Thiazolidinediones |
| 07/01/2010 | US20100168163 Cyclic-alkylamine derivatives as inhibitors of the interaction between mdm2 and p53 |
| 07/01/2010 | US20100168162 Selective inhibitors of akt and methods of using same |
| 07/01/2010 | US20100168161 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta2 adrenergic receptor |
| 07/01/2010 | US20100168160 Genipin Derivatives and Uses Thereof |
| 07/01/2010 | US20100168159 Hetero compound |
| 07/01/2010 | US20100168158 Modulators of cystic fibrosis transmembrane conductance regulator |
| 07/01/2010 | US20100168157 Preventive and therapeutic medicament for gastroesophageal reflux disease |
| 07/01/2010 | US20100168156 Novel Benzoxathiine Derivative |
| 07/01/2010 | US20100168155 DERIVATIVES OF IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDES, PREPARATION METHOD THEREOF AND USE OF SAME IN THERAPEUTICS |
| 07/01/2010 | US20100168154 1-substituted tetrahydroisoquinoline compound |
| 07/01/2010 | US20100168153 Salts and crystall forms of 2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl)-phenyl]-propionitrile |
| 07/01/2010 | US20100168152 Fat regulation |
| 07/01/2010 | US20100168151 Novel processes for preparing 6-(difluoromethoxy)[1]benzofuro[3,2-c]pyridine-9-carbaldehyde, a novel intermediate for the synthesis of pde iv inhibitors |
| 07/01/2010 | US20100168150 Camptothecin Analogue Compounds, a Process for Their Preparation and Pharmaceutical Compositions Containing Them. |
| 07/01/2010 | US20100168149 Camptothecin Analogue Compounds, a Process for Their Preparation and Pharmaceutical Compositions Containing Them |
| 07/01/2010 | US20100168148 Pharmaceutical formulation containing gelling agent |
| 07/01/2010 | US20100168147 Medicinal Compositions Comprising Buprenorphine And Naloxone |
| 07/01/2010 | US20100168146 Composition Comprising (R)-Spiro[L-Azabicyclo[2.2.2]Octane-3,2'(3'H)-Furo[2,3-B]Pyridine (AZD0328) and its Use in the Treatment of Alzheimer's Disease, ADHD or Cognitive Dysfunction |
| 07/01/2010 | US20100168145 Fused imidazole derivatives and use thereof as aldosterone synthase inhibitors |
| 07/01/2010 | US20100168144 Inhibitors of protein kinases |
| 07/01/2010 | US20100168143 Quinazoline derivatives |
| 07/01/2010 | US20100168142 Salts of 4-aniline quinazoline derivative |
| 07/01/2010 | US20100168141 Azetidine analogues nucleosidase and phosphorylase inhibitors |
| 07/01/2010 | US20100168140 Easily Absorbable Oral Preparations of Xanthine Derivatives |
| 07/01/2010 | US20100168139 Inhibitors of human phosphatidylinositol 3-kinase delta |
| 07/01/2010 | US20100168138 Anti-Viral Compounds |
| 07/01/2010 | US20100168137 Combination for use in the treatment of inflammatory disorders |
| 07/01/2010 | US20100168136 Alkylsulfone derivatives |
| 07/01/2010 | US20100168135 Method of Inducing Cleavage of Amyloid Precursor Protein to Form a Novel Fragment |
| 07/01/2010 | US20100168134 Pyridyl piperidine orexin receptor antagonists |
| 07/01/2010 | US20100168133 Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases |
| 07/01/2010 | US20100168132 Quinuclidine derivatives and their use as muscarinic m3 receptor antagonists |
| 07/01/2010 | US20100168131 Novel compounds |
| 07/01/2010 | US20100168130 Diarylmethyl Piperazine Derivatives, Preparations Thereof and Uses Thereof |
| 07/01/2010 | US20100168129 Drugs with anticholestatic activity |
| 07/01/2010 | US20100168128 Small-molecule inhibitors of the androgen receptor |
| 07/01/2010 | US20100168126 Cosmetic Use of 1-Aroyl-N-(2-oxo-3-piperidinyl)-2-piperazine Carbomamides and Related Compounds |
| 07/01/2010 | US20100168125 Indolizines and aza-analog derivatives thereof as cns active compounds |
| 07/01/2010 | US20100168124 Novel heterocyclic substituted pyridine compounds with cxcr3 antagonist activity |
| 07/01/2010 | US20100168123 Akt protein kinase inhibitors |
| 07/01/2010 | US20100168122 Xanthine derivatives as selective hm74a agonists |
| 07/01/2010 | US20100168121 Compounds with 5-ht1a activity useful for treating disorders of the outer retina |
| 07/01/2010 | US20100168120 Salts of pyridazine compounds |
| 07/01/2010 | US20100168119 Compositions and methods for minimizing or reducing agonist-induced desensitization |
| 07/01/2010 | US20100168118 Methods to Treat Cancer with 10-propargyl-10-deazaaminopterin and Methods for Assessing Cancer for Increased Sensitivity to 10-propargyl-10-deazaaminopterin |
| 07/01/2010 | US20100168117 A process for the preparation of the stable, amorphous calcium salt of (6s)-n(5)-methyl-5,6,7,8-tetrahydrofolic acid |
| 07/01/2010 | US20100168116 3,6-substituted imidazol[1,2-b]pyridazine analogs for treating allergic and inflammatory diseases |
| 07/01/2010 | US20100168115 Use of triazine derivatives for the manufacture of a medicament having a cicatrising or angiogenic effect |
| 07/01/2010 | US20100168113 Pharmaceutical Compounds |
| 07/01/2010 | US20100168112 2-Substituted and 4-substituted aryl nitrone compounds |
| 07/01/2010 | US20100168111 Polymorphic form of 5 chloro n {[(5s) 2 oxo 3 [4 (3 oxomorpholin 4 yl)phenyl]oxa-zolidin 5 yl]-methyl}thiophene 2 carboxamide |
| 07/01/2010 | US20100168110 Novel Compounds |
| 07/01/2010 | US20100168109 Pharmaceutical compositions of 1,2,4-oxadiazole benzoic acid and their use for the treatment of disease |